Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02919436 · ClinicalTrials.gov registry record · Phase 4
Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
A Phase 4 study of Post-Operative Urinary Retention, sponsored by Anand Rughani, MD.
- Completed
- Registry status
- Phase 4
- Development phase
- 610
- Enrollment target
- 1
- Study location
NCT02919436: Completed Phase 4 study of Post-Operative Urinary Retention, sponsored by Anand Rughani, MD.
NCT02919436 is a Phase 4 study of Post-Operative Urinary Retention that has completed, run by Anand Rughani, MD. The registered enrollment target is 610 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02919436, a Phase 4 study of Post-Operative Urinary Retention, has completed, sponsored by Anand Rughani, MD.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 610 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.
Primary Outcome
Postoperative urinary retention was defined as the need for any postoperative urinary catheterization for acute retention. Per hospital protocol, failure to void 6 hours after surgery or development of bladder discomfort required bladder scan. If bladder volume exceeded 300 cc, catheterization was performed.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Study Locations (1)
Maine
- Maine Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-11 |
| Phase | Phase 4 |
What the finished NCT02919436 record still lists
NCT02919436 is an interventional study that assigns participants to a tested intervention. The registered 610 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Post-Operative Urinary Retention appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02919436 reports a single indexed study location in Maine.
Frequently Asked Questions
What is clinical trial NCT02919436 about?
NCT02919436 is a clinical study titled "Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery". Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.
What is the current status of trial NCT02919436?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 610 participants. The study started on 2016-03. Estimated completion is 2020-11.
What conditions does trial NCT02919436 study?
This clinical trial studies the following conditions: Post-Operative Urinary Retention.
What interventions are being tested in trial NCT02919436?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT02919436?
This trial is sponsored by Anand Rughani, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02919436 being conducted?
This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Operative Urinary Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02919436's enrollment target sits among peer trials
610 134th of 2000 higher than 1,867 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- NCT05838638 · 610 participants · NA
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
- NCT07075718 · 610 participants · Phase 2
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia